Approvals/CIMA-AEMPS/POMBILITI 105 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

POMBILITI 105 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Amicus Therapeutics Europe Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 226345ee3d4553a4
Drug Cima Aemps Name: POMBILITI 105 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1221714001
Holder Company Name: Amicus Therapeutics Europe Limited
Marketing Company Name: Amicus Therapeutics S.L.U
Holder Company Detail Path: /organization/amicus-therapeutics-europe-limited
Authorization Date: 2023-04-25
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 105 MG
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Amicus Therapeutics Europe Limited
Company Detail Path: /organization/amicus-therapeutics-europe-limited

CIPAGLUCOSIDASA ALFA

105 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 25, 2023

Approval ID

226345ee3d4553a4

Type

Standard